187 related articles for article (PubMed ID: 32942121)
1. Modulating endothelial adhesion and migration impacts stem cell therapies efficacy.
Schäfer R; Schwab M; Siegel G; von Ameln-Mayerhofer A; Buadze M; Lourhmati A; Wendel HP; Kluba T; Krueger MA; Calaminus C; Scheer E; Dominici M; Grisendi G; Doeppner TR; Schlechter J; Finzel AK; Gross D; Klaffschenkel R; Gehring FK; Spohn G; Kretschmer A; Bieback K; Krämer-Albers EM; Barth K; Eckert A; Elser S; Schmehl J; Claussen CD; Seifried E; Hermann DM; Northoff H; Danielyan L
EBioMedicine; 2020 Oct; 60():102987. PubMed ID: 32942121
[TBL] [Abstract][Full Text] [Related]
2. Cell motility and migration as determinants of stem cell efficacy.
Danielyan L; Schwab M; Siegel G; Brawek B; Garaschuk O; Asavapanumas N; Buadze M; Lourhmati A; Wendel HP; Avci-Adali M; Krueger MA; Calaminus C; Naumann U; Winter S; Schaeffeler E; Spogis A; Beer-Hammer S; Neher JJ; Spohn G; Kretschmer A; Krämer-Albers EM; Barth K; Lee HJ; Kim SU; Frey WH; Claussen CD; Hermann DM; Doeppner TR; Seifried E; Gleiter CH; Northoff H; Schäfer R
EBioMedicine; 2020 Oct; 60():102989. PubMed ID: 32920368
[TBL] [Abstract][Full Text] [Related]
3. HMGB1-modified mesenchymal stem cells attenuate radiation-induced vascular injury possibly via their high motility and facilitation of endothelial differentiation.
Tao X; Sun M; Chen M; Ying R; Su W; Zhang J; Xie X; Wei W; Meng X
Stem Cell Res Ther; 2019 Mar; 10(1):92. PubMed ID: 30867070
[TBL] [Abstract][Full Text] [Related]
4. Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3.
De Becker A; Van Hummelen P; Bakkus M; Vande Broek I; De Wever J; De Waele M; Van Riet I
Haematologica; 2007 Apr; 92(4):440-9. PubMed ID: 17488654
[TBL] [Abstract][Full Text] [Related]
5. Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.
Behnan J; Isakson P; Joel M; Cilio C; Langmoen IA; Vik-Mo EO; Badn W
Stem Cells; 2014 May; 32(5):1110-23. PubMed ID: 24302539
[TBL] [Abstract][Full Text] [Related]
6. In vivo magnetic resonance imaging of cell tropism, trafficking mechanism, and therapeutic impact of human mesenchymal stem cells in a murine glioma model.
Chien LY; Hsiao JK; Hsu SC; Yao M; Lu CW; Liu HM; Chen YC; Yang CS; Huang DM
Biomaterials; 2011 Apr; 32(12):3275-84. PubMed ID: 21295344
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Homing of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 to Injury Site in a Mouse Model of Traumatic Brain Injury.
Shahror RA; Ali AAA; Wu CC; Chiang YH; Chen KY
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31142002
[TBL] [Abstract][Full Text] [Related]
8. Conditioned Medium from Adipose-Derived Stem Cells (ADSCs) Promotes Epithelial-to-Mesenchymal-Like Transition (EMT-Like) in Glioma Cells In vitro.
Iser IC; Ceschini SM; Onzi GR; Bertoni AP; Lenz G; Wink MR
Mol Neurobiol; 2016 Dec; 53(10):7184-7199. PubMed ID: 26687184
[TBL] [Abstract][Full Text] [Related]
9. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy.
Sasportas LS; Kasmieh R; Wakimoto H; Hingtgen S; van de Water JA; Mohapatra G; Figueiredo JL; Martuza RL; Weissleder R; Shah K
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4822-7. PubMed ID: 19264968
[TBL] [Abstract][Full Text] [Related]
10. Human Bone Marrow-Derived Mesenchymal Stem Cells Home via the PI3K-Akt, MAPK, and Jak/Stat Signaling Pathways in Response to Platelet-Derived Growth Factor.
Popielarczyk TL; Huckle WR; Barrett JG
Stem Cells Dev; 2019 Sep; 28(17):1191-1202. PubMed ID: 31190615
[TBL] [Abstract][Full Text] [Related]
11. TNF-α increases bone marrow mesenchymal stem cell migration to ischemic tissues.
Xiao Q; Wang SK; Tian H; Xin L; Zou ZG; Hu YL; Chang CM; Wang XY; Yin QS; Zhang XH; Wang LY
Cell Biochem Biophys; 2012 Apr; 62(3):409-14. PubMed ID: 22081437
[TBL] [Abstract][Full Text] [Related]
12. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
[TBL] [Abstract][Full Text] [Related]
13. Intravenous administration of bone marrow mesenchymal stem cells benefits experimental autoimmune myasthenia gravis mice through an immunomodulatory action.
Yu J; Zheng C; Ren X; Li J; Liu M; Zhang L; Liang L; Du W; Han ZC
Scand J Immunol; 2010 Sep; 72(3):242-9. PubMed ID: 20696022
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of a bone marrow mesenchymal stem cell line increases neuronal progenitor cell migration in a cerebral ischemia animal model.
Shiota Y; Nagai A; Sheikh AM; Mitaki S; Mishima S; Yano S; Haque MA; Kobayashi S; Yamaguchi S
Sci Rep; 2018 Oct; 8(1):14951. PubMed ID: 30297706
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
16. Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.
Psaltis PJ; Paton S; See F; Arthur A; Martin S; Itescu S; Worthley SG; Gronthos S; Zannettino AC
J Cell Physiol; 2010 May; 223(2):530-40. PubMed ID: 20162565
[TBL] [Abstract][Full Text] [Related]
17. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.
Noort WA; Kruisselbrink AB; in't Anker PS; Kruger M; van Bezooijen RL; de Paus RA; Heemskerk MH; Löwik CW; Falkenburg JH; Willemze R; Fibbe WE
Exp Hematol; 2002 Aug; 30(8):870-8. PubMed ID: 12160838
[TBL] [Abstract][Full Text] [Related]
19. Genetic Modification of Mesenchymal Stem Cells Overexpressing Angiotensin II Type 2 Receptor Increases Cell Migration to Injured Lung in LPS-Induced Acute Lung Injury Mice.
Xu XP; Huang LL; Hu SL; Han JB; He HL; Xu JY; Xie JF; Liu AR; Liu SQ; Liu L; Huang YZ; Guo FM; Yang Y; Qiu HB
Stem Cells Transl Med; 2018 Oct; 7(10):721-730. PubMed ID: 30133167
[TBL] [Abstract][Full Text] [Related]
20. Pre-Treatment of Human Mesenchymal Stem Cells With Inflammatory Factors or Hypoxia Does Not Influence Migration to Osteoarthritic Cartilage and Synovium.
Leijs MJ; van Buul GM; Verhaar JA; Hoogduijn MJ; Bos PK; van Osch GJ
Am J Sports Med; 2017 Apr; 45(5):1151-1161. PubMed ID: 28114800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
